These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7850004)

  • 21. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
    Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
    J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease.
    Endo T; Haraguchi K; Ohmori M; Ikeda M; Ohta K; Onaya T
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1543-7. PubMed ID: 1656957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
    Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T
    J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of thyroid stimulating immunoglobulins in a new cell line transfected with a functional human TSH receptor (JPO9 cells), compared with an assay using FRTL-5 cells.
    Michelangeli VP; Munro DS; Poon CW; Frauman AG; Colman PG
    Clin Endocrinol (Oxf); 1994 May; 40(5):645-52. PubMed ID: 7912172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases.
    Zhu Y; Portmann L; Dénéréaz N; Lemarchand-Béraud T
    Eur J Endocrinol; 1994 Oct; 131(4):359-68. PubMed ID: 7921224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease.
    Kim WB; Chung HK; Park YJ; Park DJ; Tahara K; Kohn LD; Cho BY
    Thyroid; 2000 Jul; 10(7):579-86. PubMed ID: 10958310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative correlation between the conversion of thyrotropin receptor-bound blocking type thyrotropin receptor antibody to the stimulating type by anti-human IgG antibodies and the biological activity of blocking type thyrotropin receptor antibody.
    Cho BY; Shong MH; Chung JH; Lee HK; Koh CS; Min HK
    J Korean Med Sci; 1993 Oct; 8(5):355-60. PubMed ID: 7905742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of exogenous hydrogen peroxide on iodide transport and iodine organification in FRTL-5 rat thyroid cells.
    Chen G; Pekary AE; Sugawara M; Hershman JM
    Acta Endocrinol (Copenh); 1993 Jul; 129(1):89-96. PubMed ID: 8394614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):99-106. PubMed ID: 2563181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of blocking TSH receptor antibodies on the development of hypothyroidism and thyroid atrophy in primary myxedema.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK; Sohn I
    Korean J Intern Med; 1989 Jul; 4(2):108-17. PubMed ID: 2577255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
    Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
    Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sensitive thyrotropin (TSH) bioassay based on iodide uptake in rat FRTL-5 thyroid cells: comparison with the adenosine 3',5'-monophosphate response to human serum TSH and enzymatically deglycosylated bovine and human TSH.
    Nissim M; Lee KO; Petrick PA; Dahlberg PA; Weintraub BD
    Endocrinology; 1987 Oct; 121(4):1278-87. PubMed ID: 2820695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mechanism involved in the conversion of thyrotropin receptor-bound blocking-type immunoglobulin G (IgG) to the stimulating-type by anti-human IgG antibodies.
    Taniguchi S; Yoshida A; Shigemasa C; Mitani Y; Ueta Y; Urabe K; Mashiba H
    Endocrinology; 1990 Feb; 126(2):796-803. PubMed ID: 2153526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyrotropin (TSH) receptor modulation by specific TSH receptor antibodies in Graves' disease.
    de Bruin TW; Bussemaker JK; Heidema J; Hermans J; van der Heide D
    J Clin Endocrinol Metab; 1988 Oct; 67(4):676-81. PubMed ID: 2901428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
    Lenzner C; Morgenthaler NG
    Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-TSH antibody with high specificity to human TSH in sera from a patient with Graves' disease: its isolation from, and interaction with, TSH receptor antibodies.
    Akamizu T; Mori T; Kasagi K; Kosugi S; Miyamoto M; Nishino K; Sugawa H; Yokota T; Nakamura H; Konishi J
    Clin Endocrinol (Oxf); 1987 Mar; 26(3):311-20. PubMed ID: 3652477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graves' immunoglobulin G stimulates iodide efflux in FRTL-5 thyroid cells.
    Shoda Y; Kondo Y; Kobayashi I
    J Clin Endocrinol Metab; 1993 Jul; 77(1):94-7. PubMed ID: 8100833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.